• About FESCA
  • Our Members
  • Scleroderma research
  • News & Events
  • Contact us
FESCA
New treatment investigated for SSc

New treatment investigated for SSc

April 29, 2013 | Treatment

Systemic sclerosis (SSc) is a rapidly progressing systemic form of scleroderma for which there are currently no approved treatments

Recent news

  • Buy your medicine via authorized channels
  • COVID-19 – advice for you
  • Scleroderma & COVID-19: A Conversation with the Experts
  • Message from Committee for Medicinal Products for Human Use on Ofev
  • POSTPONED: 6th World Scleroderma Patient Congress

News archive

  • March 2020
  • January 2020
  • November 2019
  • June 2019
  • April 2019
  • February 2019
  • September 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • December 2017
  • May 2017
  • November 2016
  • September 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • November 2015
  • October 2015
  • September 2015
  • July 2015
  • May 2015
  • March 2015
  • February 2015
  • November 2014
  • September 2014
  • July 2014
  • June 2014
  • May 2014
  • March 2014
  • February 2014
  • December 2013
  • June 2013
  • April 2013
  • March 2013
  • February 2013
  • June 2009

connect with us

 

Send us a message Send us a message

Like us on Facebook Like us on Facebook

Follow us on Twitter Follow us on Twitter

Follow us on Instagram Follow us on Instagram

Subscribe on Youtube Subscribe on Youtube

 

Legal disclaimer →
Data Protection Policy →

Donate today

 

Federation of European Scleroderma Associations aisbl

Rue du Pont à Rieu 13 i
7500 Saint Maur
Belgium

Federation of European Scleroderma Associations (FESCA )
© 2019 FESCA. Federation of European Scleroderma Associations is an International Non-Profit Association registered in Belgium with Registration No. FOJ 15454
We use cookies to give you the best experience on our website. By continuing to use the site we will assume you're happy with that.OKPrivacy policy